EUDAMED Mandatory from May 2026: Medical Translation as a Compliance Requirement for Medical Devices
Starting May 28, 2026, the use of the first four EUDAMED modules becomes mandatory for all new medical devices placed on the European market.
The EU MDR requires documentation to be translated into the languages of the destination Member States, turning specialized medical translation into a compliance requirement.
Medical device companies must prepare now to avoid delays in certifications and access to the European market.
The Context: MDR, EUDAMED, and Language Requirements
The EU Medical Device Regulation (MDR), fully applicable since May 2021, introduced much stricter requirements compared to previous European Directives.
Among the most critical aspects are the mandatory language requirements established under Article 41 of the MDR regulation.
Documents That Must Be Translated Under MDR
- Instructions for Use (IFU).
- Labeling and packaging.
- Technical documentation.
- Safety information.
- Clinical reports and post-market documentation.
In a market composed of 27 Member States and 24 official languages, each device may require multiple compliant language versions.
What Changes with Mandatory EUDAMED from May 28, 2026
EUDAMED is the European Database on Medical Devices, the European platform dedicated to the registration and monitoring of medical devices.
After several postponements, the system is entering its mandatory operational phase.
Mandatory EUDAMED Modules from 2026
- Module 1: Economic Operators Registration.
- Module 2: UDI and Product Registration.
- Module 3: Certificates and Notified Bodies.
- Module 5: Market Surveillance.
The modules dedicated to Vigilance and Clinical Investigations are not yet fully operational.
The introduction of EUDAMED increases the importance of terminological consistency across IFUs, labels, databases, and technical documentation.
Language inconsistencies will be easier to identify and may cause certification delays or blocks.
The MDR and IVDR Simplification Proposal
On December 16, 2025, the European Commission published a proposal to update the MDR and IVDR regulations.
Main Updates in the Proposal
- Simplified conformity procedures.
- Removal of the five-year certificate validity limit.
- New rules for medical software.
- Alignment with the AI Act.
- Simplified PRRC requirements for SMEs.
However, none of the simplifications concern language requirements.
Medical translation into the languages of Member States remains a full and non-negotiable obligation.
The Critical May 2026 Deadline for Class III Devices
May 26, 2026, represents the first cutoff date of the transition period established under Regulation (EU) 2023/607.
From this date, custom-made implantable Class III medical devices must fully comply with MDR requirements.
Manufacturers will need to complete updates to technical documentation and related compliant translations.
Waiting until later years may create bottlenecks due to the high pressure on Notified Bodies.
Why You Need a Specialized Medical Translation Partner
Translation of medical documentation cannot be entrusted to general translators or AI tools without human supervision.
Risks of Non-Compliant Translation
- Errors in IFUs with impacts on patient safety.
- Terminological inconsistencies that block certification.
- Non-compliant clinical reports that compromise the regulatory dossier.
The sector requires specific expertise in medical terminology, MDR, IVDR, and life sciences documentation.
Way2Global has been operating in medical-scientific translation for over thirty years and guarantees processes compliant with ISO 9001, ISO 17100, and ISO 18587 certifications.
Through the Way2AI division, the company integrates AI tools while maintaining specialized human oversight at every stage of the process.
Actions to Take Before May 2026
- Verify terminological consistency between IFUs, labels, technical documentation, and EUDAMED data.
- Centralize glossaries, translation memories, and approved nomenclatures.
- Work with a certified language partner specialized in the medical device sector.
In the European medical device market, translation is not an operational cost but a requirement for market access.
FAQ – Medical Device Translation and EUDAMED
What is EUDAMED?
EUDAMED is the European database dedicated to the registration of medical devices, economic operators, and market surveillance activities.
Which documents must be translated under MDR?
MDR requires the translation of IFUs, labels, technical documentation, clinical reports, and safety information into the languages of the destination Member States.
What is the MDR deadline for Class III devices?
May 26, 2026, is the deadline established for custom-made implantable Class III medical devices.
Can artificial intelligence be used in medical translation?
AI can speed up processes, but specialized human review remains essential to ensure regulatory compliance and terminological accuracy.

